The Scottish Medicines Consortium has approved the use of GlaxoSmithKline’s Avamys (fluticasone furoate) - a once-daily nasal spray for the treatment of the symptoms of allergic rhinitis – on the ...

GlaxoSmithKline <GSK.L>, Europe's biggest drugmaker, said on Tuesday its once-daily treatment for allergic rhinitis, Avamys, had been approved by the European Commission.